Skip to main content
. 2012 Apr 11;2012:452541. doi: 10.1155/2012/452541

Table 3.

Comparison of Expanded Disability Status Scale (EDSS) and relapses in 50 patients with relapsing-remitting multiple sclerosis after 12 months of treatment with low-dose vitamin D and placebo.

Treatment group Differences (95% CI)
Vitamin D (n = 25) Mean (SD) Placebo (n = 25) Mean (SD)
EDSS at 12-months 1.63 (0.70) 1.94 (1.41) −0.31 (−0.94, 0.32)
Relapses at 12-months 0.32 (0.48) 0.40 (0.58) −0.08 (−0.38, 0.22)